Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 1:01:31 Duchenne Pulmonary Care for Adults Webinar (November 2014) 11 years ago Care Webinars,Webinars 55:34 Middle Pulmonary Care Webinar (October 2014) 11 years ago Care Webinars,Webinars 47:50 Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:07:03 Prosensa Update about Drisapersen & Other Programs (October 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:05:45 Early Pulmonary Care Webinar (September 2014) 11 years ago Care Webinars,Webinars 41:57 Translarna™ (ataluren) update (June 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:09:01 Prosensa Update on Drisapersen (March 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:03:22 ACT DMD Update with PTC (February 2014) 11 years ago Research & Clinical Trial Webinars,Webinars «1…222324252627»Page 24 of 27